Literature DB >> 26006153

Excess Length of Stay Attributable to Clostridium difficile Infection (CDI) in the Acute Care Setting: A Multistate Model.

Vanessa W Stevens1, Karim Khader1, Richard E Nelson1, Makoto Jones1, Michael A Rubin1, Kevin A Brown1, Martin E Evans2, Tom Greene1, Eric Slade3, Matthew H Samore1.   

Abstract

BACKGROUND: Standard estimates of the impact of Clostridium difficile infections (CDI) on inpatient lengths of stay (LOS) may overstate inpatient care costs attributable to CDI. In this study, we used multistate modeling (MSM) of CDI timing to reduce bias in estimates of excess LOS.
METHODS: A retrospective cohort study of all hospitalizations at any of 120 acute care facilities within the US Department of Veterans Affairs (VA) between 2005 and 2012 was conducted. We estimated the excess LOS attributable to CDI using an MSM to address time-dependent bias. Bootstrapping was used to generate 95% confidence intervals (CI). These estimates were compared to unadjusted differences in mean LOS for hospitalizations with and without CDI.
RESULTS: During the study period, there were 3.96 million hospitalizations and 43,540 CDIs. A comparison of unadjusted means suggested an excess LOS of 14.0 days (19.4 vs 5.4 days). In contrast, the MSM estimated an attributable LOS of only 2.27 days (95% CI, 2.14-2.40). The excess LOS for mild-to-moderate CDI was 0.75 days (95% CI, 0.59-0.89), and for severe CDI, it was 4.11 days (95% CI, 3.90-4.32). Substantial variation across the Veteran Integrated Services Networks (VISN) was observed.
CONCLUSIONS: CDI significantly contributes to LOS, but the magnitude of its estimated impact is smaller when methods are used that account for the time-varying nature of infection. The greatest impact on LOS occurred among patients with severe CDI. Significant geographic variability was observed. MSM is a useful tool for obtaining more accurate estimates of the inpatient care costs of CDI.

Entities:  

Mesh:

Year:  2015        PMID: 26006153     DOI: 10.1017/ice.2015.132

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  13 in total

1.  The Challenges of Tracking Clostridium difficile to Its Source in Hospitalized Patients.

Authors:  Justin J O'Hagan; L Clifford McDonald
Journal:  Clin Infect Dis       Date:  2019-01-07       Impact factor: 9.079

2.  Screening for Asymptomatic Clostridium difficile Among Bone Marrow Transplant Patients: A Mixed-Methods Study of Intervention Effectiveness and Feasibility.

Authors:  Anna K Barker; Benjamin Krasity; Jackson Musuuza; Nasia Safdar
Journal:  Infect Control Hosp Epidemiol       Date:  2018-01-25       Impact factor: 3.254

3.  Inpatient Expenditures Attributable to Hospital-Onset Clostridium difficile Infection: A Nationwide Case-Control Study in Japan.

Authors:  Haruhisa Fukuda; Takahisa Yano; Nobuyuki Shimono
Journal:  Pharmacoeconomics       Date:  2018-11       Impact factor: 4.981

4.  Interventions to Reduce the Incidence of Hospital-Onset Clostridium difficile Infection: An Agent-Based Modeling Approach to Evaluate Clinical Effectiveness in Adult Acute Care Hospitals.

Authors:  Anna K Barker; Oguzhan Alagoz; Nasia Safdar
Journal:  Clin Infect Dis       Date:  2018-04-03       Impact factor: 9.079

5.  Estimating Local Costs Associated With Clostridium difficile Infection Using Machine Learning and Electronic Medical Records.

Authors:  Theodore R Pak; Kieran I Chacko; Timothy O'Donnell; Shirish S Huprikar; Harm van Bakel; Andrew Kasarskis; Erick R Scott
Journal:  Infect Control Hosp Epidemiol       Date:  2017-11-06       Impact factor: 3.254

6.  An Outbreak of Clostridium difficile Ribotype 027 Associated with Length of Stay in the Intensive Care Unit and Use of Selective Decontamination of the Digestive Tract: A Case Control Study.

Authors:  Yvette H van Beurden; Olaf M Dekkers; Marije K Bomers; Annie M Kaiser; Robin van Houdt; Cornelis W Knetsch; Armand R J Girbes; Chris J J Mulder; Christina M J E Vandenbroucke-Grauls
Journal:  PLoS One       Date:  2016-08-17       Impact factor: 3.240

7.  Lack of Association Between the Clinical Outcome of Clostridium difficile Infection and Current Steroids Use.

Authors:  Ahmed Dirweesh; Chikezie Alvarez; Muhammad Khan; Bushra Ambreen; Rishitha Yelisetti; Shaikh Fawwad Hamiz; Sana Zia; Muhammad Tahir; Vincent A DeBari; Donald Christmas; Sara Wallach
Journal:  Gastroenterology Res       Date:  2017-04-19

8.  Patient Outcomes With Prevented vs Negative Clostridioides difficile Tests Using a Computerized Clinical Decision Support Tool.

Authors:  Gregory R Madden; Kyle B Enfield; Costi D Sifri
Journal:  Open Forum Infect Dis       Date:  2020-03-18       Impact factor: 3.835

9.  Costs of hospital-acquired Clostridium difficile infections: an analysis on the effect of time-dependent exposures using routine and surveillance data.

Authors:  Thomas Heister; Martin Wolkewitz; Philip Hehn; Jan Wolff; Markus Dettenkofer; Hajo Grundmann; Klaus Kaier
Journal:  Cost Eff Resour Alloc       Date:  2019-08-01

10.  Excess length of hospital stay, mortality and cost attributable to Clostridioides (Clostridium) difficile infection and recurrence: a nationwide analysis in Japan.

Authors:  T Kimura; S Stanhope; T Sugitani
Journal:  Epidemiol Infect       Date:  2020-03-02       Impact factor: 2.451

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.